Concepedia

Short-Term Changes in Peak VO2 After Initiation of Dapagliflozin in Heart Failure Across Iron Status

Miguel Lorenzo, Conxita Jacobs-Cachá, Patricia Palau, Martina Amiguet, Julia Seller, Eduardo Núñez, Rafael de la Espriella, José Luis Górriz, Gema Miñana, Juan Sanchís,

JACC Heart Failure · 2023 · 13 citations · 18 references

DOIFull text

Open access

Concepts

References

18

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Theresa A. McDonagh, Marco Metra, Marianna Adamo et al. · European Heart Journal · 2021 · 13K citations · Full text

, , +17

Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1

Joseph T. Rodgers, Carles Lerín, Wilhelm Haas et al. · Nature · 2005 · 3.1K citations

, , +14

How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

Silvio E. Inzucchi, Bernard Zinman, David Fitchett et al. · Diabetes Care · 2017 · 747 citations

, , +15

Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics

Carlos G. Santos‐Gallego, Juan Antonio Requena-Ibáñez, Rodolfo San Antonio et al. · Journal of the American College of Cardiology · 2019 · 662 citations

, , +12

Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction

Carlos G. Santos‐Gallego, Ariana P. Vargas-Delgado, Juan Antonio Requena-Ibáñez et al. · Journal of the American College of Cardiology · 2020 · 525 citations

, , +12